00853.HK
MicroPort Scientific Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 6.08
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 996.4M | 1.0B | 950.7M | 840.8M |
| Cost of Revenue | 903.2M | 442.1M | 457.0M | 418.6M | 339.1M |
| Gross Profit | 1.1B | 554.3M | 574.1M | 532.1M | 501.8M |
| Operating Expenses | |||||
| R&D Expense | 347.7M | 135.7M | 216.5M | 379.4M | 431.0M |
| SG&A Expense | 948.7M | 465.6M | 484.7M | 540.7M | 575.8M |
| General & Admin Expense | 349.9M | 171.0M | 180.5M | 205.8M | 247.5M |
| Selling & Marketing Expense | 598.8M | 294.6M | 304.2M | 334.9M | 328.2M |
| Other Expenses | (135.6M) | 6.8M | 1.5M | 128.1M | 1.9M |
| Total Operating Expenses | 1.2B | 608.1M | 702.7M | 1.0B | 1.0B |
| Cost and Expenses | 2.1B | 1.0B | 1.2B | 1.5B | 1.3B |
| Operating Income (EBIT) | (37.1M) | (52.9M) | (128.6M) | (516.2M) | (506.6M) |
| Non-Operating | |||||
| Interest Income | 96.4M | 14.6M | 22.7M | 29.4M | 19.1M |
| Interest Expense | 202.8M | 111.4M | 102.2M | 92.7M | 73.9M |
| Net Interest Income | (178.3M) | (96.8M) | (79.5M) | (63.3M) | (54.8M) |
| Other Non-Op Income/Expense | (420.5M) | (179.9M) | (96.2M) | (110.3M) | (74.6M) |
| Non-Operating Income (excl Interest) | 142.7M | 71.2M | 13.3M | 17.6M | 656.0K |
| EBT (Pre-Tax Income) | (457.7M) | (232.8M) | (224.8M) | (626.5M) | (581.5M) |
| Income Tax Expense | 66.9M | 23.3M | 43.7M | 22.6M | 6.6M |
| Bottom Line | |||||
| Net Income | (165.3M) | 48.6M | (214.0M) | (477.6M) | (436.5M) |
| Earnings from Cont. Ops | (524.6M) | (256.1M) | (268.5M) | (649.2M) | (588.1M) |
| Earnings from Discont. Ops | 282.9M | 282.8M | — | — | — |
| Bottom Line Net Income | (178.5M) | 29.9M | (214.0M) | (477.6M) | (436.5M) |
| Per Share | |||||
| Basic EPS | (HK$0.10) | HK$0.03 | (HK$0.12) | (HK$0.27) | (HK$0.24) |
| Diluted EPS | (HK$0.10) | HK$0.02 | (HK$0.12) | (HK$0.26) | (HK$0.25) |
| Revenue Per Share | HK$1.23 | HK$0.53 | HK$0.59 | HK$0.54 | HK$0.46 |
| Shares | |||||
| Basic Shares Outstanding | 1.6B | 1.9B | 1.8B | 1.8B | 1.8B |
| Diluted Shares Outstanding | 1.9B | 2.0B | 1.8B | 1.8B | 1.8B |
| Profitability Metrics | |||||
| EBITDA | 33.9M | 88.8M | (45.3M) | (382.5M) | (430.3M) |
| D&A | 213.7M | 141.8M | 93.4M | 151.2M | 76.3M |
| EBIT | (179.8M) | (52.9M) | (138.7M) | (533.8M) | (507.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025